Acute phase response and mineral status following low dose intravenous zoledronic acid in children

Research output: Contribution to journalArticlepeer-review

Authors

  • Craig F Munns
  • Mansoor H Rajab
  • Janet Hong
  • Julie Briody
  • Wolfgang Högler
  • And 3 others
  • Mary McQuade
  • David G Little
  • Christopher T Cowell

Colleges, School and Institutes

External organisations

  • University of Sydney

Abstract

INTRODUCTION: Previous reports have shown a high frequency of hypocalcaemia and flu-like symptoms following an initial first zoledronic acid dose of 0.02-0.025 mg/kg in children.

METHODS: We systematically evaluated the mineral status and symptomatology of 63 children with a variety of bone disorders treated with an initial zoledronic acid dose of 0.0125 mg/kg. The Mann-Whitney U test, chi-squared test and Fisher's exact test were used as appropriate.

RESULTS: 0.0125 mg/kg zoledronic acid reduced the incidence and intensity of hypocalcaemia but not the incidence of the flu-like symptoms compared to higher doses. Within the low dose cohort, flu-like symptoms were associated with an acute inflammatory response. Children who became hypocalcaemic received a higher dose in relation to their body mass index and body surface area.

CONCLUSION: Reducing the initial zoledronic acid dose in children decreased the incidence of hypocalcaemia and thus improved safety. Dosing on the basis of body mass index or body surface area instead of body weight may further reduce the incidence of hypocalcaemia.

Details

Original languageEnglish
Pages (from-to)366-70
Number of pages5
JournalBone
Volume41
Issue number3
Publication statusPublished - Sep 2007

Keywords

  • Acute-Phase Reaction, Adolescent, Bone Density Conservation Agents, Bone Diseases, C-Reactive Protein, Calcium, Child, Child, Preschool, Diphosphonates, Dose-Response Relationship, Drug, Female, Humans, Hypocalcemia, Imidazoles, Infusions, Intravenous, Male, Parathyroid Hormone, Phosphates, Clinical Trial, Journal Article